Critical analysis of the 2023 ESC guidelines on cardiomyopathy management.

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Matteo Dal Ferro, Antonio De Luca, Andrea Lalario, Marco Merlo, Alessia Paldino, Maria Perotto, Carola Pio Loco Detto Gava, Jacopo Giulio Rizzi, Maddalena Rossi, Gianfranco Sinagra

Ngôn ngữ: eng

Ký hiệu phân loại:

Thông tin xuất bản: England : European heart journal supplements : journal of the European Society of Cardiology , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 237343

The first European Society of Cardiology (ESC) guidelines on the management of cardiomyopathies (CMPs), published 1 year ago, remain highly relevant. These guidelines provide a comprehensive framework to manage the complexity of CMPs, consolidating previous approaches. All CMPs are now addressed systematically in one document. The ESC recommends a 'CMP-oriented' approach, emphasizing thorough clinical assessments and phenotype-first categorization into hypertrophic, dilated, arrhythmogenic, restrictive, and non-dilated left ventricular CMP. Despite the utility of this method, certain classifications, such as arrhythmogenic right ventricular CMP and the novel non-dilated left ventricular CMP, raise controversies. Key advances in the guidelines include the use of genetic testing and cardiac magnetic resonance imaging to refine diagnoses and inform treatment, especially for high-risk genotypes. These guidelines advocate for personalized, multidisciplinary care. Overall, they represent a significant step forward but highlight the evolving nature of CMP management as scientific understanding progresses.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH